Private Equity

Updated:

Bloom8

Bloom8 is a private equity based in New York, founded 2018; the Altss profile covers its classification, headquarters, registration, AUM band, and key contacts...

Bloom8 logo

Bloom8

Bloom8, Formerly RAGE Capital merges deep sector expertise, scientific knowledge, and an unmatched network to drive industry-leading ...

General information

Firm type

Private Equity

Year founded

2018

AUM

Undisclosed

Location

Region

North America

Country

United States

City

New York

Corporate office

575 5th Ave, New York, NY 10017, United States

Additional offices

London, United Kingdom · Singapore

Principals

Alexandre Ruimy

Managing Partner

Gabriel Ruimy

Managing Partner

Brandon Chong

Managing Partner

Samy Boccara

Partner, Head of Business Development

Sector focus

AgriTech & FoodTechConsumer

Frequently asked questions

Who runs investment decisions at Bloom8?

Investment decisions are made by the Managing Partners: Alexandre Ruimy, Gabriel Ruimy, and Brandon Chong. Alexandre and Gabriel co-founded the firm in 2018. Brandon Chong brings direct food-industry experience as the former global CFO of the Joël Robuchon group, a position that gives the firm an operator lens on restaurant and consumer investments. Samy Boccara supports deal origination and portfolio development as Head of Business Development.

How is Bloom8 structured relative to the Joël Robuchon restaurant group?

Bloom8's Managing Partner Brandon Chong previously served as global CFO of the Joël Robuchon group, a fine-dining brand with international locations. The firm lists the Joël Robuchon Group among its portfolio holdings, indicating an investment relationship that creates operational overlap between Bloom8's investment team and an active restaurant platform. This hybrid structure gives the firm direct exposure to foodservice unit economics and consumer trends.

What investment stages does Bloom8 typically target?

Bloom8 targets growth-stage, late-stage, and pre-IPO companies. The firm's disclosed portfolio transactions range from $35M to $175M funding rounds, which typically corresponds to Series B through late-stage venture or pre-IPO capital. It does not describe any seed-stage or early-venture activity, and its positions in companies like Tropic Biosciences and Aleph Farms were made during rounds large enough to fund scale-up production facilities.

Does Bloom8 participate in fund commitments or only direct deals?

Available public information describes only direct investments into portfolio companies. Bloom8's website lists individual company holdings — including Aleph Farms, Remilk, and Ripple Foods — as direct portfolio positions. There is no mention of committing capital to external venture capital or private equity funds as a limited partner, suggesting the firm concentrates its capital into a curated set of direct food-system bets.

What is Bloom8's geographic investment footprint?

Bloom8 maintains offices in New York, London, and Singapore. Its disclosed portfolio spans companies headquartered in the United States (BlueNalu, Mission Barns, Ripple Foods), Brazil (Future Farm), Israel (Aleph Farms, Remilk), and Singapore. The firm's geographic focus mirrors global food consumption and production hubs rather than a single domestic market.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More New York Private Equity profiles